More than two years have passed since the onset of the COVID-19 pandemic, which has contributed to substantial global morbidity and mortality. A proportion of those acquiring COVID-19 - and surviving - continue to experience various symptoms following their acute infection phase. This phenomenon has been labelled as “Long Covid”.
Up to date, no clear definition has been established - yet long Covid is still being reported, even following the approval and dissemination of Covid vaccines. The experiences reported by the long Covid sufferers are not uniform; while some report mild persistent symptoms, others report more severe symptoms with varying durations.
The long-term sequela of long Covid is still unknown, although it is becoming clear that some individuals are more predisposed to deterrent effects compared to others. Should the persistent morbidity outcomes of long Covid be perceived as a new chronic disease? This is a research question that needs further evaluation and investigation.
In this fluid situation, gaining insight into the underlying pathophysiology, risk factors, behavioral characteristics and burden of long Covid is eminent in identifying whether a new chronic disease is emerging.
The scope of this research topic is to provide a multidisciplinary platform targeting long Covid from different fronts, including epidemiology, the burden of disease and behavioural aspects, all with the aim to bring forward multifaceted data evidence on this growing condition. Original manuscripts and review articles covering this topic would be highly appreciated.
More than two years have passed since the onset of the COVID-19 pandemic, which has contributed to substantial global morbidity and mortality. A proportion of those acquiring COVID-19 - and surviving - continue to experience various symptoms following their acute infection phase. This phenomenon has been labelled as “Long Covid”.
Up to date, no clear definition has been established - yet long Covid is still being reported, even following the approval and dissemination of Covid vaccines. The experiences reported by the long Covid sufferers are not uniform; while some report mild persistent symptoms, others report more severe symptoms with varying durations.
The long-term sequela of long Covid is still unknown, although it is becoming clear that some individuals are more predisposed to deterrent effects compared to others. Should the persistent morbidity outcomes of long Covid be perceived as a new chronic disease? This is a research question that needs further evaluation and investigation.
In this fluid situation, gaining insight into the underlying pathophysiology, risk factors, behavioral characteristics and burden of long Covid is eminent in identifying whether a new chronic disease is emerging.
The scope of this research topic is to provide a multidisciplinary platform targeting long Covid from different fronts, including epidemiology, the burden of disease and behavioural aspects, all with the aim to bring forward multifaceted data evidence on this growing condition. Original manuscripts and review articles covering this topic would be highly appreciated.
